Jeremy Grantham acquired 286 Thousand Gilead Sciences shares worth $18.9 Million. That's 0.08% of their equity portfolio (171st largest holding). The first Gilead Sciences trade was made in Q1 2013. Since then Jeremy Grantham bought shares twenty more times and sold shares on eighteen occasions. The investor's estimated purchase price is $19.1 Million, resulting in a loss of 0.9%.